- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/31 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Patent holdings for IPC class C07K 14/31
Total number of patents in this class: 794
10-year publication summary
58
|
54
|
58
|
69
|
58
|
58
|
51
|
58
|
48
|
20
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cytiva BioProcess R&D AB | 303 |
50 |
Affibody AB | 114 |
34 |
The University of Chicago | 1392 |
26 |
Glaxosmithkline Biologicals S.A. | 1640 |
24 |
Navigo Proteins GmbH | 109 |
22 |
Roche Sequencing Solutions, Inc. | 640 |
20 |
Kaneka Corporation | 4496 |
16 |
Children's Medical Center Corporation | 1857 |
14 |
New York University | 1736 |
14 |
Evaxion Biotech A/S | 51 |
12 |
The Regents of the University of California | 19859 |
10 |
JSR Corporation | 2516 |
10 |
GE Healthcare Bio-Sciences AB | 544 |
10 |
EMD Millipore Corporation | 649 |
9 |
The Trustees of the University of Pennsylvania | 4311 |
9 |
Repligen Corporation | 283 |
9 |
Socpra Sciences et Genie S.E.C. | 197 |
8 |
GE Healthcare BioProcess R&D AB | 42 |
8 |
Abvacc, Inc. | 13 |
8 |
The University of Western Ontario | 320 |
7 |
Other owners | 474 |